Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1976 1
1977 4
1978 10
1979 9
1980 13
1981 15
1982 25
1983 23
1984 16
1985 12
1986 12
1987 11
1988 17
1989 15
1990 2
1991 6
1992 6
1993 3
1994 3
1995 5
1996 6
1997 4
1998 3
1999 11
2000 6
2001 4
2002 3
2003 4
2004 5
2005 6
2006 5
2007 2
2008 8
2009 9
2010 10
2011 6
2012 6
2013 10
2014 11
2015 14
2016 9
2017 19
2018 13
2019 18
2020 23
2021 23
2022 25
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

464 results

Results by year

Filters applied: . Clear all
Page 1
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.
Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Hosomi Y, et al. Among authors: minato k. J Clin Oncol. 2020 Jan 10;38(2):115-123. doi: 10.1200/JCO.19.01488. Epub 2019 Nov 4. J Clin Oncol. 2020. PMID: 31682542 Clinical Trial.
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR.
Miyauchi E, Morita S, Nakamura A, Hosomi Y, Watanabe K, Ikeda S, Seike M, Fujita Y, Minato K, Ko R, Harada T, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Miyauchi E, et al. Among authors: minato k. J Clin Oncol. 2022 Nov 1;40(31):3587-3592. doi: 10.1200/JCO.21.02911. Epub 2022 Aug 12. J Clin Oncol. 2022. PMID: 35960896 Free PMC article. Clinical Trial.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
John T, Sakai H, Ikeda S, Cheng Y, Kasahara K, Sato Y, Nakahara Y, Takeda M, Kaneda H, Zhang H, Maemondo M, Minato K, Hisada T, Misumi Y, Satouchi M, Hotta K, Li A, Oukessou A, Lu S. John T, et al. Among authors: minato k. Int J Clin Oncol. 2022 Apr;27(4):695-706. doi: 10.1007/s10147-022-02120-0. Epub 2022 Feb 19. Int J Clin Oncol. 2022. PMID: 35182247 Free PMC article. Clinical Trial.
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.
Shiono A, Imai H, Wasamoto S, Tsuda T, Nagai Y, Minemura H, Yamada Y, Kishikawa T, Umeda Y, Takechi H, Yamaguchi O, Mouri A, Kaira K, Taniguchi H, Minato K, Kagamu H. Shiono A, et al. Among authors: minato k. Cancer Med. 2023 Jan;12(1):73-83. doi: 10.1002/cam4.4938. Epub 2022 Jun 14. Cancer Med. 2023. PMID: 35699088 Free PMC article.
Chitosan nanofiber.
Ohkawa K, Minato K, Kumagai G, Hayashi S, Yamamoto H. Ohkawa K, et al. Among authors: minato k. Biomacromolecules. 2006 Nov;7(11):3291-4. doi: 10.1021/bm0604395. Biomacromolecules. 2006. PMID: 17096563 No abstract available.
Reply to letter to the editor by Sato et al.
Shoji H, Ohashi M, Yajiri Y, Minato K, Yahata M, Wakasugi M, Sawakami K, Watanabe K. Shoji H, et al. Among authors: minato k. J Orthop Sci. 2023 May;28(3):714. doi: 10.1016/j.jos.2023.02.021. Epub 2023 Mar 7. J Orthop Sci. 2023. PMID: 36894402 No abstract available.
464 results